American Radium Society ™ Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer
Recent randomized studies have suggested improvements in progression-free and overall survival with the addition of stereotactic body radiation therapy (SBRT, also known as stereotactic ablative radiotherapy, SABR) in oligometastatic NSCLC patients. Given the novelty and complexity of incorporating SBRT in the oligometastatic setting, the multidisciplinary American Radium Society (ARS) Lung Cancer Panel was assigned to create Appropriate Use Criteria (AUC) on SBRT as part of consolidative local therapy for oligometastatic and oligoprogressive NSCLC patients.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Arya Amini, Vivek Verma, Charles B. Simone, Indrin J. Chetty, Stephen G. Chun, Jessica Donington, Martin J. Edelman, Kristin A. Higgins, Larry L. Kestin, Benjamin Movsas, George B. Rodrigues, Kenneth E. Rosenzweig, Igor I. Rybkin, Benjamin J. Slotman, And Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Physics | Radiation Therapy | Radiology | Study